Medicine

Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France

A. Singier, Stéphane Vignot, D. Desplas, M. Zureik, N. Haddy

2026.5.1BIODRUGS

DOI: 10.1007/s40259-026-00778-w

Abstract

Abstract is not available.

Citation format

SINGIER, A., et al. Correction: Real-world use of dostarlimab plus chemotherapy in advanced or recurrent endometrial cancer: A nationwide cohort study in france. BIODRUGS, 2026, 40(3): 565–565.